The results of this study show that the CD3+CD4+ and CD3+CD8+ counts were significantly lower in patients with hepatitis B during fucoidan supplementation than before the initiation of treatment with fucoidan, but increased after treatment, and that these counts were higher than those observed before the initiation of fucoidan supplementation. Here, CD8A is linked to hepatitis B virus infection.